Health Condition 1: K30- Functional dyspepsia
Conditions
Interventions
Intervention1: Standard triple therapy with probiotic supplementation: Proton pump inhibitor amoxicillin and clarithromycin along with probiotic supplementation as per standard protocol
Control Interv
Sponsors
ACS Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients aged above 18 years with Helicobacter pylori positive dyspepsia confirmed by urea breath test attending the general Surgery department and willing to give informed consent
Exclusion criteria
Exclusion criteria: Patients with history of peptic ulcer diseases or malignancies and use of antibiotics or proton pump inhibitors or probiotics in the last four weeks and also known allergy to any drug in the triple therapy regimen and also pregnant or lactating women and patients with severe comorbidities or immunosuppression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori infectionTimepoint: Four weeks after completion of therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of gastrointestinal side effects and patient compliance to therapy and improvement in dyspeptic symptomsTimepoint: During treatment and up to four weeks after completion of therapy | — |
Countries
India
Contacts
Public ContactDr Ananya Sarmah
ACS Medical College and Hospital
Outcome results
None listed